Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2016 by GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: March 1, 2012
Last updated: January 11, 2016
Last verified: January 2016
This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.

Condition Intervention
Infections, Rotavirus
Other: Data collection

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Assessing the Number of Rotavirus Related Hospitalizations in 11 Hospitals in Belgium - Season 2006-2007

Resource links provided by NLM:

Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • Determination of the absolute number of rotavirus related hospitalisations in children up to five years old. [ Time Frame: From June 1st 2006 up to 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Classification of patients with rotavirus hospitalisation by birth cohorts, gender, time of the event, vaccine coverage status. [ Time Frame: From June 1st 2006 up to 1 year ] [ Designated as safety issue: No ]
  • Determination of the duration of rota-related hospitalisation for community acquired and nosocomial infection per birth cohort. [ Time Frame: From June 1st 2006 up to 1 year ] [ Designated as safety issue: No ]
  • Evaluation of the herd effect. [ Time Frame: From June 1st 2006 up to 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 1
Study Start Date: February 2016
Estimated Study Completion Date: March 2016
Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Group A
All children ≤ 5 years old with a rotavirus detection test (inpatient and ambulatory tests) performed during the period of June the 1st 2006 and May the 31st 2007.
Other: Data collection
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2006- May 31st 2007) and analysed for rotavirus, in children aged ≤5 years.

Detailed Description:
This retrospective study will use anonymised data, extracted from hospital databases during the period of the 1st of June 2006 until the 31st of May 2007. IMS Health sales data will be used to provide rotavirus vaccine coverage estimates (Rotarix and Rotateq) for the Belgian population during the study period. Any additional source of vaccine coverage status describing rotavirus vaccine uptake in the study population will also be reported.

Ages Eligible for Study:   up to 5 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children aged ≤5 years undergoing a RV detection test across 11 participating hospitals.

Inclusion Criteria:

  • Child aged ≤5 years;
  • A stool sample has been provided for a rotavirus detection test during the study period;
  • Laboratory test result of rotavirus is available.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01563146

Contact: US GSK Clinical Trials Call Center 877-379-3718

Sponsors and Collaborators
Study Director: GSK Clinical Trials GlaxoSmithKline
  More Information

Responsible Party: GlaxoSmithKline Identifier: NCT01563146     History of Changes
Other Study ID Numbers: 116311 
Study First Received: March 1, 2012
Last Updated: January 11, 2016
Health Authority: Belgium: Ministry of Health

Keywords provided by GlaxoSmithKline:

Additional relevant MeSH terms:
Rotavirus Infections
RNA Virus Infections
Reoviridae Infections
Virus Diseases processed this record on May 24, 2016